Embecta Corp. (EMBC) stock
EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3080% below fair value
$6.15−0.10 (-1.60%)
Close on Nov 17, 2026Market cap $348.46MP/E 4.2Yield 9.76%
Embecta operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Embecta's operating cash flow for the twelve months ending Jun 30, 2026 was $174.10M, up 29.6% year over year. For fiscal 2025 it was $191.70M, up 437.0% from the year before. The highest annual figure on record is $498.50M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $191.70M | +437.0% |
| FY2024 | Sep 30, 2024 | $35.70M | -47.3% |
| FY2023 | Sep 30, 2023 | $67.70M | -83.6% |
| FY2022 | Sep 30, 2022 | $412.20M | -9.7% |
| FY2021 | Sep 30, 2021 | $456.30M | -8.5% |
| FY2020 | Sep 30, 2020 | $498.50M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $41.80M | -48.5% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $31.10M | -2.2% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $17.20M | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $84.00M | +215.8% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $81.20M | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $31.80M | +30.9% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$5.30M | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $26.60M | -10.1% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -$2.10M | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $24.30M | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$13.10M | -121.7% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $29.60M | -49.0% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$9.30M | -128.4% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$13.00M | -107.1% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $60.40M | -56.5% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $58.00M | -32.2% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $32.80M | -74.7% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $182.60M | +52.5% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $138.80M | +14.3% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $85.50M | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $129.70M | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $119.70M | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $121.40M | – |
See a number that looks wrong?